Valeant CEO J. Michael Pearson delivers expansion news to Bausch + Lomb employees

Valeant Pharmaceuticals ($VRX) CEO J. Michael Pearson took a break this week from defending the company's price hike strategies to deliver good news to employees at the company's Bausch + Lomb plant in Greenville, SC. After bottle number 4 billion rolled off a contact solutions line there, Pearson told employees Valeant intends to invest up to $150 million over the next 5 years to expand capacity at the plant. He said the investments will mean as many as 200 jobs for the plant, which currently employs 500. More from FiercePharmaManufacturing

Suggested Articles

Turns out Procter & Gamble didn’t want Pfizer’s consumer health unit after all. But it did want Merck KGaA’s.

Private equity firm, in exclusive talks with Sanofi, says it'll invest to pump up Zentiva into an "independent European generics leader."

With suitor Takeda circling Shire, the Dublin-based target has pulled off a deal of its own.